Lisata Therapeutics, Inc. (LSTA) Financials

$2.43

$0.03 (1.25%)
Last update: 12:50 PM EST
Day's range
$2.42
Day's range
$2.67
$150M$150M$100M$100M$50M$50M$0$0-$50M-$50M-$100M-$100MEarning201820182019201920202020202120212022202220232023202420240%0%-500%-500%-1000%-1000%-1500%-1500%-2000%-2000%-2500%-2500%Profit Margin
Profit Margin
Revenue
Earnings

LSTA Income statement / Annual

Last year (2024), Lisata Therapeutics, Inc.'s total revenue was $1.00 M, and the percentage change from the previous year is not available. In 2024, Lisata Therapeutics, Inc.'s net income was -$19.99 M. See Lisata Therapeutics, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Operating Revenue $1.00 M $0.00 $121.37 M $0.00 $0.00 $0.00 $0.00 $0.00 $35.28 M $22.49 M
Cost of Revenue $174.00 K $189.00 K $57.60 M $55.00 K $63.00 K $65.00 K $225.00 K $372.00 K $450.27 K $20.16 M
Gross Profit $826.00 K -$189.00 K $63.77 M -$55.00 K -$63.00 K -$65.00 K -$225.00 K -$372.00 K $4.15 M $2.33 M
Gross Profit Ratio 0.83 0 0.53 0 0 0 0 0 0.12 0.1
Research and Development Expenses $11.33 M $12.73 M $43.46 M $17.68 M $9.25 M $13.50 M $7.59 M $17.14 M $15.11 M $23.90 M
General & Administrative Expenses $12.08 M $12.97 M $14.14 M $11.37 M $9.89 M $9.30 M $9.39 M $11.75 M $12.80 M $0.00
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $12.08 M $12.97 M $14.14 M $11.37 M $9.89 M $9.30 M $9.39 M $11.75 M $20.38 M $30.01 M
Other Expenses $0.00 $0.00 -$155.00 K -$75.00 K -$1.60 M -$2.70 M $824.00 K -$1.30 M $21.96 K $17.72 M
Operating Expenses $23.41 M $25.71 M $57.60 M $29.05 M $19.15 M $20.09 M $16.99 M $27.59 M $35.48 M $53.91 M
Cost And Expenses $23.41 M $25.71 M $57.60 M $29.05 M $19.15 M $20.09 M $16.99 M $27.59 M $29.50 M $74.06 M
Interest Income $0.00 $2.72 M $0.00 $151.00 K $132.00 K $740.00 K $0.00 $0.00 $0.00 $0.00
Interest Expense $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $5.00 K $377.77 K $1.86 M $2.13 M
Depreciation & Amortization $174.00 K $189.00 K $69.00 K $55.00 K $63.00 K $65.00 K $225.00 K $372.00 K $450.27 K $2.69 M
EBITDA -$22.24 M -$25.52 M -$115.20 M -$29.15 M -$19.08 M -$20.03 M -$16.76 M -$27.22 M -$29.03 M -$93.44 M
EBITDA Ratio -22.24 0 -0.95 0 0 0 0 0 -0.82 -4.16
Operating Income Ratio -22.41 0 -0.22 0 0 0 0 0 -0.89 -2.29
Total Other Income/Expenses Net $1.63 M $2.54 M $897.00 K $76.00 K $132.00 K $740.00 K $819.00 K -$105.00 K -$1.76 M -$46.68 M
Income Before Tax -$20.78 M -$23.17 M -$56.70 M -$28.97 M -$19.01 M -$19.35 M -$16.17 M -$27.70 M -$31.26 M -$98.25 M
Income Before Tax Ratio -20.78 0 -0.47 0 0 0 0 0 -0.89 -4.37
Income Tax Expense -$798.00 K -$2.33 M -$2.48 M -$1.51 M -$10.87 M $749.00 K -$1.00 K -$11.53 M $138.04 K -$17.24 M
Net Income -$19.99 M -$20.84 M -$54.23 M -$27.47 M -$8.15 M -$20.10 M -$16.17 M $22.98 M -$32.66 M -$80.89 M
Net Income Ratio -19.99 0 -0.45 0 0 0 0 0 -0.93 -3.6
EPS -2.4 -2.58 -10.47 -7.45 -7.91 -29.2 -25.03 38.43 -74.81 -250.12
EPS Diluted -2.4 -2.58 -10.47 -7.45 -7.91 -29.2 -25.03 38.43 -74.81 -250.12
Weighted Average Shares Out $8.33 M $8.07 M $5.18 M $3.69 M $1.03 M $688.33 K $645.93 K $859.34 K $436.55 K $323.39 K
Weighted Average Shares Out Diluted $8.33 M $8.07 M $5.18 M $3.69 M $1.03 M $688.33 K $645.93 K $597.93 K $436.55 K $323.39 K
Link